News & Events
Neuros in the Media
News Releases
-
Neuros Medical Announces Completion of QUEST Pivotal Trial 90-day Primary Endpoints
-
Neuros Medical Announces Completion of Enrollment in the QUEST Pivotal Clinical Study for Chronic Post-Amputation Pain
-
Neuros Medical Receives FDA Breakthrough Device Designation for its Novel Altius® High Frequency Nerve Block System
-
Neuros Medical Raises $38.5M in Series BB Funding for Completion of Pivotal Clinical Study for Chronic Post-Amputation Pain
-
Neuros Medical Announces Key Milestones in the QUEST Pivotal Clinical Study for Chronic Post-Amputation Pain
-
Neuros Medical Appoints Tom Wilder as President and CEO
-
Neuros Medical Announces Closing of $20 Million Venture Financing